Disease block
G35-G37 – Demyelinisierende Krankheiten des Zentralnervensystems
- Chapter VI: Krankheiten des Nervensystems
19Decisions
30Patient groups
Added benefit by patient group
- Minor8
- Non-quantifiable2
- Not proven20
Diseases in this disease block
Decisions, newest first
Each decision lists only the patient groups coded with a disease in this disease block.
- 2024-08-01BriumviUblituximabMinor: 1 of 2 patient groupsNot proven: 1 of 2 patient groups
- 2024-01-18TecfideraDimethylfumaratNot proven
- 2023-12-07UltomirisRavulizumabNot proven
- 2023-01-19UpliznaInebilizumabNot proven
- 2022-05-19PonvoryPonesimodMinor: 1 of 2 patient groupsNot proven: 1 of 2 patient groups
- 2022-01-20AubagioTeriflunomidNot proven
- 2022-01-06EnspryngSatralizumabMinor
- 2021-12-02PonvoryPonesimodNot proven
- 2021-01-07ZeposiaOzanimodMinor: 1 of 2 patient groupsNot proven: 1 of 2 patient groups
- 2020-08-20MayzentSiponimodNot proven: 2 of 2 patient groups
- 2019-06-20GilenyaFingolimodNon-quantifiable: 2 of 4 patient groupsNot proven: 2 of 4 patient groups
- 2018-11-01SativexExtrakt aus Cannabis sativaMinor
- 2018-08-02OcrevusOcrelizumabMinor: 2 of 3 patient groupsNot proven: 1 of 3 patient groups
- 2018-05-17MavencladCladribinNot proven: 2 of 2 patient groups
- 2016-05-19GilenyaFingolimodNot proven: 2 of 2 patient groups
- 2015-10-01GilenyaFingolimodMinor
- 2014-10-16TecfideraDimethylfumaratNot proven
- 2014-03-20AubagioTeriflunomidNot proven
- 2012-08-02FampyraFampridinNot proven
Data status: 2026-10-29